Regulatory & Policy Intelligence
Strategic monitoring of global regulatory evolution, accelerated approval frameworks and pharmaceutical compliance developments.
Regulatory reform directly influences drug approval timelines, market access dynamics and innovation incentives across major jurisdictions.
What Is Hidden Behind ‘Low-Cost CAR-T’? Global Regulators Are Cracking Down
July 11, 2026
Learn why global regulators are cracking down on low-cost CAR-T therapy programs, the hidden risks behind gray-market cell therapies, and how patients can identify legitimate CAR-T treatment providers.
What Increases the Risk of Brain Tumors? Understanding the Main Risk Factors
July 10, 2026
Learn the major risk factors for brain tumors, including ionizing radiation, inherited genetic syndromes, age, family history, immune dysfunction, and the latest advances in brain tumor risk prediction and precision medicine.
From FDA to NMPA: How Global Drug Regulatory Systems Are Fighting the Spread of Counterfeit Medicines
July 10, 2026
Explore how the FDA, China’s NMPA, and the European Union are strengthening pharmaceutical regulation through digital traceability, supply chain security, and anti-counterfeit technologies to protect patients worldwide.
Why Does the Epstein-Barr Virus Cause Nasopharyngeal Carcinoma? Understanding High-Risk Factors and Early Warning Signs
July 09, 2026
Learn how Epstein-Barr virus (EBV) contributes to nasopharyngeal carcinoma (NPC), discover high-risk factors, early warning signs, screening methods, and the latest advances in precision medicine and innovative therapies.
A Milestone for Targeted Protein Degradation: The World’s First PROTAC Drug Approved
July 06, 2026
The U.S. FDA has approved Vepdegestrant (Veppanu), the world’s first PROTAC therapy, for ER-positive, HER2-negative, ESR1-mutant advanced or metastatic breast cancer—marking a historic milestone for targeted protein degradation.
Understanding the FDA Pregnancy Drug Classification and Procurement Recommendations: From A/B/C/D/X to PLLR—How Can Pharmacies Optimize Medication Management for Pregnant Patients?
June 30, 2026
How to Safely Switch Between Warfarin and NOACs: Key Timing and Monitoring Considerations
June 30, 2026
Why Can’t Patients with Liver or Kidney Impairment Use the Same Standard Drug Dosage?
June 29, 2026
Treatment Guideline Updates: Which Drugs May Be Marginalized by Changes in Clinical Recommendations?
June 29, 2026
Five Innovative Drugs Approved in China on the Same Day: Breakthroughs in Bispecific Antibodies, ADCs, and Solid Tumor CAR-T
June 27, 2026
Chronic Disease Medication Management: How to Choose Lipid-Lowering Therapies for Dyslipidemia?
June 26, 2026
Oral Weight-Loss Drug Welcomes a New Competitor: AI-Designed Drug MDR-001 Enters Phase III Clinical Trials
June 16, 2026
AI-designed oral weight-loss drug MDR-001 has officially entered Phase III clinical trials in China, highlighting the growing role of artificial intelligence in pharmaceutical innovation and obesity treatment.
Why Do Patients Often Have More Treatment Options After a Drug Patent Expires?
June 16, 2026
Explore how drug patent expiration influences generic drugs, biosimilars, pharmaceutical competition, medicine accessibility, and patient treatment options worldwide.
The First AI-Designed Drugs Enter Clinical Trials: A Historic Breakthrough for the Pharmaceutical Industry
June 16, 2026
Artificial intelligence is reshaping pharmaceutical innovation as the world’s first AI-designed drugs enter clinical trials, accelerating drug discovery, reducing development costs, and opening new possibilities for precision medicine and rare disease treatments.
AI-Powered Precision Medicine: How Data-Driven Innovation Is Accelerating Personalized Drug Development
June 12, 2026
How Broad Is Health Insurance Coverage? Understanding the Protection Boundaries for Cross-Border Medical Care
June 04, 2026
Learn what health insurance covers for overseas medical treatment, including public insurance, private insurance, international medical insurance, innovative therapies, and common coverage gaps in cross-border healthcare.
How to Identify and Avoid Medical Scams: A Practical Guide Before Seeking Cross-Border Healthcare
June 04, 2026
Learn how to identify common medical scams, verify healthcare providers, and protect yourself when pursuing overseas treatment, international consultations, or cross-border medication access.
Drug Safety Differences: A Comparative Analysis Across Global Regions
June 02, 2026
China’s Innovative Gene Therapy Approved for Market
June 01, 2026
Profits from Weight-Loss Drugs Fuel a Growing Gray Market: How Can Global Pharmaceutical Regulation Achieve Long-Term Governance?
May 29, 2026
As demand for GLP-1 weight-loss drugs surges worldwide, counterfeit medicines, illegal compounded products, and gray-market supply chains are rapidly expanding.